Innovative Medical Technology

Neurotron, Incorporated

   Innovative Medical Technology

                 Established 1981

Neurometer® Clinical Nephrology Applications

 Patient Care


 Press Releases






 Clinical Apps







  Nephrologists use sNCT/CPT studies to evaluate patients with kidney disease to assist in determining when to commence dialysis therapy. The study is prescribed when clinical examination findings suggest development of an impairment in distal sensory function and an objective evaluation is required to confirm and evaluate a diagnosis of polyneuropathy. Typically, the distal great toe test site is tested bilaterally and if a polyneuropathy is detected then dialysis therapy may be considered to attempt to reverse the condition and/or prevent its progression. Normal sNCT/CPT evaluation results indicate that no further sNCT/CPT testing is necessary unless a change in the clinical condition suggesting sensory dysfunction requires an evaluation. Nephrologists also prescribe the sNCT/CPT study to be administered to endstage renal disease patients to provide an index of the long-term adequacy of dialysis therapy.

Additionally, sNCT/CPT studies of the distal phalanges of the fingers may assist in the diagnosis of suspected Carpal Tunnel Syndrome (CTS) in dialysis patients. Fifty percent of patients receiving dialysis for six years or more develop CTS without experiencing the classical CTS symptoms due to concurrent upper extremity polyneuropathy. Left untreated, patients with CTS may suffer significant impairment of the affected hand.

top of page      Previous page     Home



The entire contents of this web site are Copyright 1996-2010, Neurotron, Incorporated

Est. 1981, Baltimore, MD, USA.  All rights reserved, worldwide

rev 10/16/09